Search for: "Wang v. Does" Results 21 - 40 of 371
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Oct 2016, 2:06 pm
 Justice Hull's opinion doesn't discuss it, but the fourth paragraph of Section 846 provides that "[t]his section does not limit the liability which otherwise exists . . . [read post]
27 Jun 2019, 2:49 pm by Jon Levitan
This morning the court issued a 5-4 opinion in Department of Commerce v. [read post]
19 Jul 2021, 1:21 pm by Amanda Frost
In April 2020, a month after New York Times reporter Adam Liptak wrote about Covert and Wang’s data, the Supreme Court denied a request by the SG’s office to participate in oral argument as amicus in support of Ford Motor Co. in Ford v. [read post]
5 Aug 2021, 8:43 am by Allan Blutstein
Pending FOIA Case Has Major Implications For Trial Data DisclosureBy Beth Wang, inside Health Policy, Aug. 4, 2021 In a case with major implications for what kinds of clinical trial information can be made public, HHS and Sarepta Pharmaceuticals are asking a federal appeals court to uphold a lower court decision that FDA does not have to disclose confidential clinical trial information on Sarepta’s Duchenne muscular dystrophy drug, Exondys 51. [read post]
30 Nov 2014, 12:00 am
Consider, for the moment, the case of State v. [read post]
9 Sep 2013, 12:02 pm by Seyfarth Shaw LLP
Co-authored by Sheryl Skibbe and Kevin Young With last week’s denial of the plaintiffs’ request for a full panel rehearing in Wang v. [read post]
16 Dec 2015, 3:10 am by Matrix Legal Information Team
He stated that refusal to permit disclosure to the ECtHR does not constitute a breach of international law. [read post]
24 Oct 2013, 12:00 am
Wang’s decision does, indeed, look foolish. [read post]